Breathe
Breathe
COPD is the fourth-largest cause of hospital admission as primary diagnosis, and a high proportion of patients are admitted through the emergency room as unplanned hospitalisations. In recent years, new strategies of patient empowerment and alternatives to hospitalisation have aimed to decrease admissions and reduce the burden on healthcare services. As the prevalence of chronic disorders increases, a holistic approach to disease management, involving patients, carers and all levels of healthcare provision, is needed in order to improve prognosis. A major project is under way in three European countries to prepare for the widespread introduction of information technology-dependent integrated care services.
Correspondence J. Roca Servei de Pneumologia (ICT) Hospital Clnic Villarroel 170 08036 Barcelona Spain Fax: 34 932275455 E-mail: [email protected]. For further information on the ICT platform and services: www.nexeshealth.eu
with cancer, patients with COPD or cardiac disorders were mostly admitted through the emergency room as unplanned hospitalisations. It is well known that cardiac diseases, COPD and type II diabetes show a high degree of clustering [68]. Moreover, there is an unacceptably high rate of readmissions in patients with chronic disorders [9]. Taken together, the data indicate the need for re-examining the management of COPD patients who have exacerbations, in order not only to enhance the efficacy of care during exacerbations, but also to prevent admissions due to severe exacerbations in frail patients. In view of the high social and economic burden generated by COPD hospitalisations, new strategies aiming to decrease admissions through patient empowerment and implementation of alternatives to conventional hospitalisation have been developed in recent years [1016]. Short-stay units, respiratory day hospitals and home-based programmes, such as home hospitalisation, are good examples of
27
including the adoption of a new health paradigm fitting the needs of chronic care.
Primary care
Home
Figure 1 Evolving trends of healthcare to support integrated care services. Shared-care arrangements among levels of care are required to apply patient-oriented clinical guidelines.
Figure 2 Diagram of the integrated care model proposed by the WHO's ICCC initiative. As represented in the figure, interplay between the roles of patients/carers, healthcare/public health and community services is needed. (See [1922] for further explanations).
innovative services addressing COPD patients. Integrated care interventions bridging the gap between primary care and respiratory specialists with the support of (ICT) have been shown to be effective in preventing unplanned hospitalisations in COPD patients [17]. Ongoing small-scale pilot experiences in Europe, such as the European Union-funded Better Breathing project [18], are exploring the potential of integrated care services to address care pathways that cover the whole spectrum of COPD, from early diagnosis to endstage disease, including end-of-life support. It should be noted, however, that a holistic approach to integrated care in chronic patients needs to look beyond prevention and/or management of crises. Instead, the principal targets should be early diagnosis and prevention together with future personalised care strategies launched at early stages of COPD and aiming at modulation of disease progress and enhancement of prognosis. Successful strategies to address these challenges entail a progressive phasing-out of the classical disease management approach in favour of patient-oriented strategies,
The Chronic Care model
Community supporters
ed orm Inf
Healthcare team
Mo tiv ate
28
talisation. Strategies for prevention of unplanned hospitalisations have also been successfully explored [10, 17], but they may not be financially sustainable in the long term. A common problem in all these pilot studies is that disease-specific trials have shown high internal validity, but a questionable external validity because of their high exclusion rates [17], mainly due to severe comorbid conditions (~60% exclusion of cases). These could potentially be managed through wider programmes addressed to frail patients with multiple severe chronic disorders. The second most important exclusion factor, often present in frail patients, is a lack of appropriate social support. As suggested previously, the current focus on advanced chronic conditions needs to be shifted toward the development of preventive integrated care strategies, addressed to people in the early stages of (or even at high risk of developing) chronic disorders. The ultimate aim should not be solely to manage disease, but to improve the prognosis of chronic disorders. For this, highly standardised interventions together with continuous evaluation of results will be required. In order to face all these challenges, more attention is being paid to the evolution of health systems from a provider-centred perspective to a patient-focused approach. This is an essential development if the epidemiological changes associated with population ageing and the growing prevalence of chronic disorders are to be addressed successfully [30]. Significant changes in healthcare organisation and education are urgently needed in order to prepare healthcare professionals for new and evolving roles. In this new scenario, a major issue will be the extensive use of ICT as a tool for the public to access the system in new ways, and as a medium to effectively promote information sharing among professionals, the public and formal and informal caregivers. While the role of ICT in supporting innovative integrated care services is unquestionable, there are several unsolved issues. Any platform must be modular to enable expansion and robust through redundancy. Co-development and interoperability of ICT platforms are major technological elements contributing to sustainability. These technological challenges must be overcome to achieve standardisation and ensure shared arrangements across levels of care. The final aim is primarily concerned with normalising service delivery practices and integrating them seamlessly with ICT. The above elements must go hand in hand with the necessary financial rear-
rangements, supported by well-defined business cases [3239]. The rationale is that the interplay among these factors will favour the implementation of new systems in daily practice, leading to growth in provision and uptake. The transitional phase from existing pilot experiences to extensive deployment of health and social services targeting selected groups entails a choice of which target services should be validated. They are selected on the basis of the knowledge and experience acquired through small-scale controlled pilot studies showing positive outcomes in terms of efficiency, user satisfaction and overall cost savings [9, 17], and they cover a broad spectrum of health problems, from those affecting citizens at risk or in the early stages of disease to those characterising patients with advanced chronic disorders. It is important to note that there are significant gaps in the methodology of validating innovative healthcare services supported by ICT. These partly explain the lack of data formally validating the role of ICT in healthcare. The current approach is to use RCTs, although health technology assessment agencies and experts acknowledge the need for new and more appropriate methodological approaches conceived specifically for validating healthcare services and their associated ICT tools.
Figure 3 The four integrated care services described in the text will be developed in the three sites. Interoperability among sites will be explored through collaboration with the large-scale pilot study (SOS).
Gateway access
Statistics
Sensors
Application severs
29
adapting regional healthcare services to face new demographic and lifestyle challenges and the increased prevalence of chronic illnesses. It will run in Spain, Norway and Greece (figure 3) in close relationships with a large European project (SOS) that includes 12 countries, aiming at crosscountry interoperability of electronic prescriptions and patient summary reports. NEXES will also look for strong interactions with other regional deployment studies. The main objective is to evaluate the potential for generalisation of four specific services targeting people at risk and patients with chronic illnesses. NEXES will mainly address patients with one or more of COPD, chronic heart failure and type II diabetes. The central hypotheses of the project are that integrated care based on standardised pathways supported by ICT may enhance clinical outcomes and generate satisfaction for patients, carers and health professionals. It may contain costs by preventing duplication. Moreover, it may have a positive impact on disease progress and prognosis. Should all (or some) of these outcomes happen, the sustainability of the healthcare model promoted by NEXES will be ensured. The project outlines the need to consider three pivotal aspects for a successful deployment: organisational issues, including workflow redesign and redefinition of the roles of the public and professionals; the legal and ethical implications associated with these changes; and the educational needs of professionals and the public. NEXES will tackle a range of challenges posed by changing healthcare needs. Sharing between different levels of healthcare (primary care being central) and reformulating the role of nurses as case managers. Strengthening the active role of the public in disease prevention and management. Developing treatment strategies centred on the patient, which facilitate the
Box 1
management of comorbidities. Improving communication between healthcare services and community support services. Stratifying needs and personalising healthcare. Developing new accessibility and communication methods between patients and the healthcare system. In this scenario, ICT plays a fundamental support role. At the same time, there are significant technological requirements. ICT platforms must be modular and interoperable. There must be support for sharing information and decisions among healthcare levels and community services , and with patients and carers. Specific and/or continued remote monitoring of selected patients must be available. Support tools must be provided for managing clinical knowledge, prediction and personalisation of the healthcare service. Services will be validated through large-scale RCTs including more than 5,000 patients. The services have been selected on the basis of smallscale controlled pilot studies as detailed earlier in this article. The first three services described in Box 1 address important aspects related to chronic patients. The target groups for these services will be patients with heart failure, type II diabetes and COPD. The fourth service (Support) will encompass a variety of heterogeneous niches wherein ICT has a clear potential to play a relevant role enhancing home-based healthcare delivery. All services will be assessed in three distinct locations (Barcelona, Spain; Central Norway; and Athens, Greece), despite some existing differences in the specifics of healthcare organisation. The impact of heterogeneities among sites will be evaluated. The differences among sites may offer
Wellness and rehabilitation promoting healthy lifestyles in clinically stable chronic patients, enhancing their selfmanagement and improving compliance with prescribed pharmacological and nonpharmacological interventions. Among the latter, physical activity and muscle training will be the principal components. Enhanced care for frail patients to prevent unplanned hospitalisations. Home hospitalisation of chronic patients with severe exacerbations aiming at optimisation of home hospitalisation, enhancing interactions with primary care and reducing the rate of readmissions. Support for diagnosis and/or therapeutic procedures including collaborative tools for professionals working at different healthcare levels to enhance their potential for action in home-based interventions.
30
opportunities to plan cross-border co-developments for the deployment phase. One of the primary objectives of NEXES is to provide robust results to health technology assessment agencies and decisionmakers in order to facilitate the extensive deployment of the services and the sustainability of the care model (table 1).
Table 1
1 2 3 4 5
Assessment of clinical effectiveness of four services through large field studies Evaluation of associated costs (direct and indirect) for each type of service Analysis of factors influencing extensive deployment of the services. Proposal of strategies for adoption. Analysis of associated business models Analysis of cross-country issues relevant to the transfer of information/knowledge among the three sites Identification of leading teams across Europe willing to share NEXES experience and stimulation of synergies with other platforms
domised (1:1 ratio) to the intervention arm with mobile technologies or a control arm with conventional care. The two groups will be followed up for 18 months. Phase II of the study will have a similar design and purposes, but will include 500 patients with COPD and/or heart failure and have a shorter (4-week) supervised training period. The ICT platform will include mobile phones with questionnaires, messaging and wireless sensors (pulse oximetry and physical activity), a call centre and a web-based application for professionals and patients/carers, including telecollaboration tools. Target variables and expected results are: 1) improved health status; 2) longterm sustainability of training-induced physiological effects of skeletal muscle training; 3) increased adherence to treatment; 4) improved lifestyle; and 5) reduction in healthcare expenses. 2. Enhanced care for frail patients In 2006, we reported that a standardised lowintensity integrated care intervention, with the support of a web-based call centre and a portable system used by specialised nurses during home visits, prevented hospitalisations in COPD patients who were included in the study immediately after hospital discharge and followed up for 12 months [17]. Shared care agreements with primary care teams were a key element in the success of the intervention. The study showed significant cost savings and satisfaction of patients and professionals involved. A similar study in COPD patients at high risk of unplanned hospitalisation was carried out during 2006 [40]. The study showed the potential of wireless systems for patient self-monitoring at home, as well as the beneficial impact of integrated care to reduce emergency room visits, increase planned hospitalisations and reduce mortality. Current data on the impact of chronic conditions in tertiary care hospitals suggests that enhanced care services for frail patients are needed promptly. Identified target clusters of dis-
31
eases were chronic heart failure, COPD and diabetes type II. While the pilot studies were essentially triggered from the hospital side, in NEXES they should be driven at primary care level, with hospital specialists playing a supporting role. A second important aim of the project is to explore whether results obtained in disease-oriented pilots (COPD) can be reproduced in patient-oriented programmes addressing different disease conditions. It is well known that disease-oriented pilots show high internal validity, but limited potential for generalisation. The study will be an RCT with 1,400 patients, 700 each in the integrated and conventional care arms. The patients will be followed up for 12 months. The integrated care intervention will consist of the following. Comprehensive assessment of the patient including severity of main disease, evaluation of comorbid conditions and analysis of social support requirements. Educational programme on self-management of the disease administered at discharge. Individually tailored care plan following international guidelines shared across the healthcare system. Setting up interactions between the primary care team, community services and the specialised team. The logistics of the interventions will be customised to suit the specifics of the healthcare organisation in each of the three sites. The ICT platform and associated services will comprise: 1) mobile phones including questionnaires and messaging services; 2) wireless sensors for selected patients in the intervention group; 3) call centre; 4) a mobile application (laptop) with wireless sensors for home-visiting professionals; and, 5) a web-based application for professionals and patients/carers with telecollaboration tools. The expected results are: 1) improved health status; 2) a fall in emergency room and unscheduled hospital admissions; 3) decrease in length of stay; 4) increased adherence to treatment; 5) changes in lifestyle; and 6) a reduction of costs. 3. Home hospitalisation and early discharge of chronic patients with severe exacerbations In 2003, we reported that an integrated homecare intervention in selected COPD exacerbations was cost-effective [9, 11, 37]. Home hospitalisation generated better outcomes at a lower cost than conventional care. We concluded that home-based services should not be seen in opposition to in-patient hospitalisation. They must be
regarded as part of the continuum of care in chronically ill patients. The study revealed a need for the deployment of this type of intervention as a regular healthcare service for COPD patients who suffer exacerbations, under the frame of a properly designed cost-effectiveness analysis. Since early 2006, a home-hospitalisation programme has been deployed in several acute and chronic conditions, showing that with proper reengineering of the system this type of programme is effective for patients and increases the number of available beds for other healthcare programmes. In NEXES, home hospitalisation has two main aims: 1) to evaluate the added value of a robust ICT platform in improving interactions with patients/carers and the interplay of the programme with primary care services; and 2) to generalise the home-hospitalisation programme to other centres. This programme is mainly a hospital-driven initiative, but share care agreements with primary care services should be explored in order to increase efficiencies. The hypothesis is that home hospitalisation with robust ICT support will enable the generalisation of a sustainable service. The study will be an RCT (1:1 ratio) with 2,400 patients. Candidates will be patients with acute episodes of exacerbation of chronic conditions. The types of patients with acute problems requiring emergency room admission who showed acceptable clinical outcomes in the Hospital Clnic (Barcelona) programme during 20062007 will also be considered for inclusion in the project. Current inclusion criteria are: 1) emergency room admission or hospitalisation for <48 hours; 2) carer available 24 hours per day; 3) ability to understand the programme; and 4) signed consent form. Exclusion criteria are: 1) presence of major comorbid conditions such as advanced cancer, stroke, etc.; and 2) living in a nursing home. The intervention group will receive the following. Comprehensive assessment, including severity of main disease, evaluation of comorbid conditions and analysis of requirements in terms of social support. Educational programme on self-management of the disease administered at discharge. Individually tailored care plan following international guidelines. Logistics for home support including enabling ICT tools. Access to the system during the follow-up period through an ICT platform including a web-based call centre. The technological platform and support serv-
32
ices will include mobile phone with questionnaires and messaging, along with wireless sensors for remote monitoring in selected patients. A call centre and mobile application (laptop) with wireless sensors will be provided for home-visiting professionals. Moreover, a web-based application including telecollaboration tools will be available to professionals and patients/carers. The expected results are: 1) a reduction in hospitalisations and readmissions; 2) a decrease in mortality rate; 3) satisfaction; and 4) cost containment. We expect that it will be possible to expand the inclusion criteria, optimise the burden on the professionals and decrease the impact of these patients on primary care. 4. Support The programme will provide support for diagnosis and/or therapeutic procedures including collaborative tools for professionals working at different healthcare levels to enhance their potential for action in home-based interventions. The main goal of the programme is to expand the potential of primary care professionals by facilitating the use of diagnostic and therapeutic technologies, with potential remote support (mostly offline) from specialists. A recent study carried out with 4,500 patients in Spain showing the usefulness of a simple web-based application to enhance the quality of forced spirometry in primary care [46] is one example of such activity. The potential to transfer decision-making capabilities to primary care and patient's home is spectacular. It holds out the prospect of new ways of interaction between all levels of healthcare, including patients/carers. No doubt the role of specialists will change for good. This specific study encompasses a heterogeneous group of services, covering potential applications of the available ICT platform to remotely support different health services. It comprises: Remote control of tertiary care programmes (arrhythmias, pulmonary hypertension, minimally invasive systems, etc.) whose deployment is currently limited because of a lack of proper organisational integration. Support for specific monitoring between hospital and home. This could be valid for major ambulatory surgery or highly sophisticated home programmes (bonemarrow transplantation). For obvious reasons, it is difficult to address the methodological issues involved in this programme and the specificities of the evaluation. It is clear that services, not technology, will be
evaluated. It has to be assumed that the technology is proven and robust. Up to 700 cases have been targeted for this study, but the project will include more patients than this. The technological requirements will be as already described for the other three services.
l ll
Computersupported Services Customer cooperative work provided relationship e-medication Electronic management Performance patient management e-Education l records
l
Payers
Portal
l l l l l
Stakeholders
Public authorities
33
Box 2
System functionalities
New business models Business mix ICT modularity/scalability New type of consumer Ethical aspects Cost-effectiveness
Patient empowerment functionalities These aim to allow the patient to be more proactive in the management of his/her conditions and to increase adherence to treatment. It features educational material and strategy to deliver it. Examples: Text-messaging system to promote treatment compliance or warnings Streamed video to promote exercise and weight control Personal diary to keep track of progress Patient self-monitoring functionalities These functionalities characterise monitoring in terms of its type, the resources needed (sensors, questionnaires, etc.), scheduling, display features for the patients, etc. Example: Short questionnaire to assess symptoms, administered periodically, either scheduled or nonscheduled, via a mobile phone. An evolving graph for the main variables is presented to the patient and a more complex one to the professional Patientprofessional communication functionalities These include the main features of the equipment used and how it should be invoked or customised to the pattern of care. Example: A patient could access the control centre in three different ways: phone call via call centre; SMS alarm triggered from mobile phone; via the portal application. Professionalprofessional communication functionalities The different capabilities for professional collaboration are included in this group. Examples: Virtual boards E-mail Shared agendas Video conference
Figure 5 Dimensions of long-term viability in NEXES are seen as the confluence of a set of six basic elements depicted in the figure. It also aims at representing some differences according to their importance and contribution to viability. The bottom block includes three dimensions that are seen as sine qua non for sustained maintenance of the services of NEXES. It includes cost-effectiveness, ethical aspects and the emergence of a new type of consumer.
disease phenotype and its associated prognosis. For example, a COPD patient with mild-tomoderate disease whose data suggest slow disease progress with no systemic effects may be advised to follow a care path involving a high degree of self-management with low impact on the healthcare system. In contrast, a patient with features indicating rapid progress of lung disease and future development of systemic effects will be monitored closely with a view to relatively high intensity interventions at early COPD stages in order to modulate the disease progress. In this scenario, we can envisage an optimistic view of COPD. Management of crises (exacerbations) will no longer be the central clinical problem of the disease and COPD will essentially be managed outside the hospital. Moreover, early interventions based on a deep knowledge of the underlying mechanisms of the disease will facilitate modulation of disease progress, with marked positive effects on prognosis.
References 1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 12691276. 2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Workshop summary. Am J Respir Crit Care Med 2001; 163: 12561276. Updated 2007 at www.goldcopd.com 3. Garcia-Aymerich J, Farrero E, Flez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100105. 4. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 27942800. 5. Hernandez C, Nuez M, Vidal M, Bertran MJ, Roca J, Jansa M. High prevalance of chronic disorders in patients admitted in a tertiary hospital. Impact of co-mobordities on use of resources. Am J Respir Crit Care Med 2007; 175: A600.
34
6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46.
Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370: 797799. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 627643. Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 24782484. Hernandez C, Casas A, Escarrabill J, et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Respir J 2003; 21: 5867. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585591. Ram FS, Wedzicha JA, Wright J, Greenstone M. Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. BMJ 2004; 329: 315. Gravil JH, Al Rawas OA, Cotton MM, Flanigan U, Irwin A, Stevenson RD. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet 1998; 351: 18531855. Skwarska E, Cohen G, Skwarski KM, et al. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax 2000; 55: 907912. Cotton MM, Bucknall CE, Dagg KD, et al. Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Thorax 2000; 55: 902906. Davies L, Wilkinson M, Bonner S, Calverley PM, Angus RM. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomized controlled trial. BMJ 2000; 321: 12651268. Sala E, Alegre L, Carrera M, et al. Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD. Eur Respir J 2001; 17: 11381142. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006; 28: 123130. Better Breathing. www.betterbreathing.org Date last accessed: August 5, 2008. Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet 2005; 366: 16671671. Wagner EH. The role of patient care teams in chronic disease management. BMJ 2000; 320: 569572. Wagner EH. Meeting the needs of chronically ill people. BMJ 2001; 323: 945946. Wagner EH, Glasgow RE, Davis C, et al. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv 2001; 27: 6380. Horton R. The neglected epidemic of chronic disease. Lancet 2005; 366: 1514. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 14361442. Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of health care for chronic conditions. Qual Saf Health Care 2004; 13: 299305. van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet 2006; 367: 550555. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 11901195. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 1999; 354: 10771083. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care 1999; 22: 20112017. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA 2001; 285: 182189. Kimball JJB. Innovative Care Delivery Models: Identifying New Models that Effectively Leverage Nurses. Princeton, The Robert Wood Johnson Foundation, 2008. Ruchlin HS, Dasbach EJ. An economic overview of chronic obstructive pulmonary disease. Pharmacoeconomics 2001; 19: 623642. Salazar A, Corbella X, Sanchez JL, Argimon JM, Escarrabill J. How to manage the ED crisis when hospital and/or ED capacity is reaching its limits. Report about the implementation of particular interventions during the Christmas crisis. Eur J Emerg Med 2002; 9: 7980. Sullivan SD, Ramsey, SD, Lee TA. The economic burden of COPD. Chest 2000; 117: Suppl.2, 5S9S. Shepperd S, Harwood D, Gray A, Vessey M, Morgan P. Randomized controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimization analysis. BMJ 1998; 316: 17911796. Coast J, Richards SH, Peters TJ, Gunnell DJ, Darlow MA, Pounsford J. Hospital at home or acute hospital care? A cost minimization analysis. BMJ 1998; 316: 18021806. Puig-Junoy J, Casas A, Font-Planells J, et al. The impact of home hospitalization on healthcare costs of exacerbations in COPD patients. Eur J Health Econ 2007; 8: 325332. Briggs AH, O'Brien BJ. The death of cost-minimisation analysis? Health Econ 2001; 10: 179184. Dixon J, Lewis R, Rosen R, Finlayson B, Gray D. Can the NHS learn from US managed care organizations? BMJ 2004; 328: 223226. Hernandez C, Lozano L, Alonso A, et al. Enhanced care services to reduce unplanned admision in high risk COPD patients are ready for extensive deployment. Am J Respir Crit Care Med 2008; 77: A841. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Ant JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007; 175: 458463. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Ant JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772778. Spruit MA, Vanderhoven-Augustin I, Janssen PP, Wouters EF. Integration of pulmonary rehabilitation in COPD. Lancet 2008; 371: 1213. Peterson PN, Magid DJ, Ross C, et al. Association of exercise capacity on treadmill with future cardiac events in patients referred for exercise testing. Arch Intern Med 2008; 168: 174179. Cherkas LF, Hunkin JL, Kato BS, et al. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 2008; 168: 154158. Burgos F, Disdier C, Roger N, et al. Tele-collaboration enhances quality of forced spirometry in primary care. Am J Respir Crit Care Med 2008; 77: A144.
35